658875 external_news 1655234062 1655234062 A group of researchers from the University of Missouri, Georgia Institute of Technology, and Harvard University has proved the successful use of a novel Type 1 diabetes treatment in a large animal model in a new study published in Science Advances. Their method includes transferring insulin-producing pancreas cells, known as pancreatic islets, from a donor to a recipient without the need for long-term immunosuppressive medicines. The Georgia Tech team includes Andres Garcia, executive director of the Parker H. Petit Institute for Bioengineering and Biosciences (IBB);  María M. Coronel, IBB postdoctoral fellow; and Michael Hunckler, bioengineering Ph.D. candidate. 

]]> 2022-06-14 1278 1275